Rituximab Protects Insulin Producing Cells in Diabetes (CME/CE)

Patients with new-onset type 1 diabetes were modestly better able to retain beta cell function after treatment with the B-cell depleting agent rituximab (Rituxan), researchers said.

source : www.medpagetoday.com

Related News:

• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)
• Older Women with Gout at Risk of MI (CME/CE)

Details :
Submited at Wednesday, November 25th, 2009 at 7:01 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback